Afference develops the Phantom, a wireless haptic glove that uses neural stimulation to create artificial touch sensations, allowing users to feel digital interactions without physical contact. This technology enhances user experience in virtual, augmented, and mixed reality environments by bridging the gap between the digital and physical worlds.

Alviere provides a white-label financial services platform that enables organizations to embed customizable financial products, such as accounts, wallets, and card issuance, directly into their existing offerings. This integration enhances customer engagement, generates new revenue streams, and streamlines financial operations for various industries, including retail and telecommunications.

Clarametyx Biosciences Inc. develops immune-enabling biologic therapies that target biofilms, the protective barriers surrounding bacteria, to combat life-threatening infections. Their technology aims to reduce antibiotic resistance by providing an alternative approach to traditional antibiotic treatments.

Enable Injections develops the enFuse wearable drug delivery platform, which allows patients to self-administer large volumes of medication subcutaneously through a hands-free system. This technology provides a more comfortable and convenient alternative to intravenous administration, enhancing the patient treatment experience.

Eridu AI develops semiconductor technology to enhance the performance of large AI models by addressing infrastructure bottlenecks that limit GPU utilization, leading to inefficiencies in training cycles and inference speed. Their solutions aim to significantly reduce costs and power consumption associated with AI model deployment.

FenixPyre is a data security platform that employs file-level encryption to protect sensitive data throughout its lifecycle, ensuring files remain secure while in use, in transit, and at rest. The platform mitigates risks associated with ransomware, insider threats, and compliance challenges by providing automated data governance and seamless secure file sharing for organizations.

Immuta offers a unified data access governance platform that centralizes metadata, automates data discovery, and enforces attribute‑based access policies across cloud data stores such as Snowflake, Databricks, and BigQuery. The solution provides self‑service request workflows, real‑time policy enforcement, and consolidated audit logs to streamline compliance for large enterprises.

Invirsa develops INV-102, a molecule that enhances ocular DNA repair and boosts the innate immune response to infections and injuries, particularly in cases of sulfur mustard gas exposure and acute infectious keratoconjunctivitis. This treatment aims to improve cellular stability and promote effective recovery, addressing the significant risk of permanent vision damage and the lack of approved therapies for viral conjunctivitis.

Lentechs is developing a patented line of soft, suspended bifocal contact lenses that utilize the eye's anatomy to provide clear vision at all distances. This technology addresses the needs of the 120 million U.S. patients with presbyopia who prefer contact lenses over glasses but often experience inadequate visual correction with existing options.

Niobium develops hardware accelerators designed to significantly boost the performance of Fully Homomorphic Encryption (FHE) software. This custom PCIe hardware supports all major FHE schemes, enabling organizations to process sensitive data while it remains encrypted. The solution makes Zero Trust Computing feasible by providing high-speed, low-power acceleration for encrypted computation.

S4 Medical has developed the esolution® device, the only FDA-cleared tool that provides bilateral deviation of the esophagus during catheter ablation for atrial fibrillation, reducing the risk of thermal injury. This device is compatible with any ablation energy source and significantly decreases the incidence of esophageal injury, which affects up to 47% of patients undergoing such procedures.

ScriptDrop connects pharmacies with a network of trained couriers to facilitate the timely delivery of prescription medications. This service addresses the challenge of medication access, ensuring patients receive their prescriptions conveniently and reliably.

Trace provides a platform for creating, managing, and publishing augmented reality (AR) experiences across various devices. The tools enable users to design immersive content quickly using mobile apps or a web studio, supporting persistent anchoring and scalable hosting. This service allows brands and creators to deploy spatial computing applications for retail, training, and exhibitions without extensive development time.